ACE Inhibition with Moexipril: A Review of Potential Effects Beyond Blood Pressure Control

By Pines A.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 5, 2003-01 ,pp. : 351-360

Adis International

Access to resources Recommend Favorite

Cardiovascular Outcomes and Angiotensin Converting Enzyme Inhibitors: Beyond Blood Pressure Control: Editorial to: “Secondary Prevention of Coronary Disease with ACE Inhibition—Does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA?” by Remme et al.

By Verma Anil   Ventura Hector  

Cardiovascular Drugs and Therapy, Vol. 23, Iss. 2, 2009-04 ,pp. : 109-111

Springer Publishing Company

Access to resources Recommend Favorite

Vasopeptidase inhibition attenuates proteinuria and podocyte injury in Zucker diabetic fatty rats

By Fredersdorf Sabine   Weil Joachim   Ulucan Coskun   Birner Christoph   Büttner Roland   Schubert Thomas   Böger Carsten   Debl Kurt   Muders Frank   Riegger Günter   Luchner Andreas  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 2, 2007-04 ,pp. : 95-103

Springer Publishing Company

Access to resources Recommend Favorite

Control of Blood Pressure in the Community: An Unsolved Problem

By  

Current Pharmaceutical Design, Vol. 9, Iss. 29, 2003-11 ,pp. : 2375-2384

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Blood Pressure Control in Cardiovascular Prevention

By  

Current Pharmaceutical Design, Vol. 22, Iss. 37, 2016-10 ,pp. : 5649-5661

Bentham Science Publishers

Access to resources Recommend Favorite